Cargando…
Atopic Dermatitis and Comorbidity
Atopic dermatitis is the most common chronic inflammatory skin disease. It is often the first indicator of allergic diseases, and a certain percentage of patients are affected by allergic rhinitis and/or asthma as a consequence. The study aimed to investigate the link between atopic dermatitis and c...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349599/ https://www.ncbi.nlm.nih.gov/pubmed/32218222 http://dx.doi.org/10.3390/healthcare8020070 |
_version_ | 1783557092204871680 |
---|---|
author | Bekić, Sanja Martinek, Vjenceslav Talapko, Jasminka Majnarić, Ljiljana Vasilj Mihaljević, Mila Škrlec, Ivana |
author_facet | Bekić, Sanja Martinek, Vjenceslav Talapko, Jasminka Majnarić, Ljiljana Vasilj Mihaljević, Mila Škrlec, Ivana |
author_sort | Bekić, Sanja |
collection | PubMed |
description | Atopic dermatitis is the most common chronic inflammatory skin disease. It is often the first indicator of allergic diseases, and a certain percentage of patients are affected by allergic rhinitis and/or asthma as a consequence. The study aimed to investigate the link between atopic dermatitis and comorbidity in family medicine. In the specialist family medicine practice Osijek, a retrospective study was conducted in the period from January 1, 2016 to July 1, 2017 on the percentage of patients with atopic dermatitis in the total number of patients, and their comorbid diseases. The data source was the E-chart. The results showed that 195 (10.53%) out of 2056 patients had atopic dermatitis, 80 (41%) patients had atopic dermatitis and allergic rhinitis, 34 (17.4%) asthma, 132 (67.7%) infections, 59 (30.3%) gastrointestinal disturbances, and 68 (34.3%) had mental disorders. Patients up to 18 years old were more likely to have infections, and adult patients were exposed to chronic stress. The most commonly used drug was loratadine (60.5%), while mometasone was the most commonly administered topical drug (40%). The result of this research showed the steps of the ˝atopic march˝. Atopic dermatitis is followed by changes in the skin and its progression to other organ systems in most of the patients. |
format | Online Article Text |
id | pubmed-7349599 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-73495992020-07-14 Atopic Dermatitis and Comorbidity Bekić, Sanja Martinek, Vjenceslav Talapko, Jasminka Majnarić, Ljiljana Vasilj Mihaljević, Mila Škrlec, Ivana Healthcare (Basel) Article Atopic dermatitis is the most common chronic inflammatory skin disease. It is often the first indicator of allergic diseases, and a certain percentage of patients are affected by allergic rhinitis and/or asthma as a consequence. The study aimed to investigate the link between atopic dermatitis and comorbidity in family medicine. In the specialist family medicine practice Osijek, a retrospective study was conducted in the period from January 1, 2016 to July 1, 2017 on the percentage of patients with atopic dermatitis in the total number of patients, and their comorbid diseases. The data source was the E-chart. The results showed that 195 (10.53%) out of 2056 patients had atopic dermatitis, 80 (41%) patients had atopic dermatitis and allergic rhinitis, 34 (17.4%) asthma, 132 (67.7%) infections, 59 (30.3%) gastrointestinal disturbances, and 68 (34.3%) had mental disorders. Patients up to 18 years old were more likely to have infections, and adult patients were exposed to chronic stress. The most commonly used drug was loratadine (60.5%), while mometasone was the most commonly administered topical drug (40%). The result of this research showed the steps of the ˝atopic march˝. Atopic dermatitis is followed by changes in the skin and its progression to other organ systems in most of the patients. MDPI 2020-03-25 /pmc/articles/PMC7349599/ /pubmed/32218222 http://dx.doi.org/10.3390/healthcare8020070 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bekić, Sanja Martinek, Vjenceslav Talapko, Jasminka Majnarić, Ljiljana Vasilj Mihaljević, Mila Škrlec, Ivana Atopic Dermatitis and Comorbidity |
title | Atopic Dermatitis and Comorbidity |
title_full | Atopic Dermatitis and Comorbidity |
title_fullStr | Atopic Dermatitis and Comorbidity |
title_full_unstemmed | Atopic Dermatitis and Comorbidity |
title_short | Atopic Dermatitis and Comorbidity |
title_sort | atopic dermatitis and comorbidity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349599/ https://www.ncbi.nlm.nih.gov/pubmed/32218222 http://dx.doi.org/10.3390/healthcare8020070 |
work_keys_str_mv | AT bekicsanja atopicdermatitisandcomorbidity AT martinekvjenceslav atopicdermatitisandcomorbidity AT talapkojasminka atopicdermatitisandcomorbidity AT majnaricljiljana atopicdermatitisandcomorbidity AT vasiljmihaljevicmila atopicdermatitisandcomorbidity AT skrlecivana atopicdermatitisandcomorbidity |